JEREMY BAKER: Open Payments
NPI 1295373785 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,705 in 122 payments from 42 companies in 2025. Trend: 2023 $1,287 · 2024 $2,330 · 2025 $2,705
Food & beverage: $2,705
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $309 |
| Amgen Inc. | 12 | $250 |
| Novo Nordisk Inc | 18 | $238 |
| Lilly USA, LLC | 8 | $223 |
| Dexcom, Inc. | 5 | $109 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $87 |
| Soleno Therapeutics, Inc. | 2 | $72 |
| Mannkind Corporation | 2 | $72 |
| Exact Sciences Corporation | 2 | $70 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, Ozempic, EVENITY, Dexcom G6 Transmitter, AIRSUPRA, ISTURISA, JARDIANCE.
Industry payments across CT — which companies pay providers there.
